Colonic Polyp
Conditions
Brief summary
Linked color imaging (LCI) was recently developed and uses a laser endoscopic system (Fujifilm Co, Tokyo, Japan) that acquires images by simultaneously using narrow-band short-wavelength light and white-light (WL) in an appropriate balance. LCI is a new image-enhancing technology that is intended to enhance slight color differences in the red region of the mucosa. The acquired color information is reallocated to differentiate colors that are similar to the mucosal color, resulting in improved performance in depicting blood vessels, and additional image processing that enhances color separation for red color permits clear visualization of red blood vessels and white pits. This modality may increase the detection rate of colorectal polyps by enhancing the visibility of colonic mucosal vessels. In addition, it has been reported that LCI increases the visibility of colorectal flat lesions and contributes to improvement of the detection rate for these lesions. The primary aim of the current study was to compare the detection rate of colorectal flat lesions of LCI cap-assisted colonoscopy with WL cap-assisted colonoscopy in prospective randomized trial. In addition, we prospectively compared LCI and WL with regard to the visibility of colorectal flat lesions found in this study.
Interventions
PROCEDURELinked-color imaging
Linked-color imaging colonoscopy
Sponsors
Showa Inan General Hospital
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
DIAGNOSTIC
Masking
SINGLE (Investigator)
Eligibility
Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* We enrolled consecutive patients who were referred for colonoscopy to our hospital for diagnostic work up of colonic symptoms, surveillance of colorectal polyps, and colorectal cancer screening.
Exclusion criteria
* familial colorectal cancer syndrome including familial adenomatous polyposis and hereditary non-polyposis colorectal cancer syndrome, personal history of colorectal cancer or inflammatory bowel disease and those who had previous colonic resection. Patients who were considered to be unsafe for polypectomy, including patients with bleeding tendency and those with severe comorbid illnesses, were excluded. Those in whom \<90% of mucosa was seen due to mixture of semisolid and solid colonic contents were also excluded because of poor bowel preparation.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Average prevalence of flat lesion /patient detected | procedure | The total number of flat colorectal lesion/patient was defined. The average prevalence of flat lesion /patient detected was calculated. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Adenoma detection rate | procedure | Adenoma detection rate was defined as the proportion of patients with at least one adenoma found on colonoscopy. |
| Polyp detection rate | procedure | Polyp detection rate was defined as the proportion of patients with at least one polyp found on colonoscopy. |
Other
| Measure | Time frame | Description |
|---|---|---|
| The visibility of colorectal flat lesions | 1 day | Six endoscopists interpreted the images of CLI and WL. By using a previously reported visibility scale, we scored the visibility level on a scale of 1 to 4 and compared the two groups. |
Countries
Japan
Outcome results
None listed